bm-navigation: bm-t1-home-navigation-1
bm-pageheader: bm-t2-aboutus-pageheader

Endpoints – Arch joins Celgene, China investors bankrolling a pioneering New York biotech startup focused on a new approach to metastasis

Endpoints – Arch joins Celgene, China investors bankrolling a pioneering New York biotech startup focused on a new approach to metastasis

Julio Aguirre-Ghiso has steered the work in his lab at Mount Sinai down some of the less-traveled pathways of cancer research. And it’s led him to launch a biotech — which is having its coming-out party today in New York — that has now set out to develop new medicines tailored for the field he’s been pioneering.

Read full story by John Carroll here.